HHY-15912-56212
3 vaccinations
2 coded responses
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 954 / CA
- Registered
- 2021-06-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-27
Dose 1 — Pfizer-BioNTech
-
2021-06-12
Registered in v-safe
- 2021-06-12
-
2021-06-17
Dose 2 — Pfizer-BioNTech
-
2021-06-17
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-06-20
-
2021-06-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-23
- 2021-06-24
- 2021-07-01
- 2021-07-08
- 2021-07-15
- 2021-07-22
- 2021-07-31
- 2021-09-18
- 2021-12-16
-
2022-04-13
Dose 3 — Pfizer-BioNTech
-
2022-04-13
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-04-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-04-16
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessFree text: Lymph nodes sore and swollenMedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-18
- 2022-04-19
- 2022-04-20
- 2022-04-27
- 2022-05-08
- 2022-05-16
- 2022-05-20
- 2022-05-27
- 2022-10-12
-
2023-04-13
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-13
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-04-14
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-27 | Pfizer-BioNTech | |
| 2 | 2021-06-17 | Pfizer-BioNTech | |
| 3 | 2022-04-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-13 | Successful 2023-04-14 |
Does not wish to fill out VAERS report |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph nodes sore and swollen
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release